English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Tinnitus UK urges new policies after campaign highlights risks in live music settings

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Colorado man seeks treatment at Ohio State after rare brain tumor diagnosis

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Understanding frozen shoulder: causes, treatment options and outlook

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

How families can support seniors facing memory-related tech challenges

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA cites design flaws in rejecting REGENXBIO Hunter syndrome gene therapy

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Boehringer Ingelheim ends MASH partnership with OSE after failed phase 2 trial

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

North Carolina town emerges as key hub for next-gen obesity drug production

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Experts question centralized decision-making trend at FDA after Moderna vaccine case

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily